Do you want to read an article? Please log in or register.
Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials
Stroke
Related content
Alcohol Use Disorder (AUD)
Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials
JAMA Psychiatry.
Falk DE, O'Malley SS, Witkiewitz K, Anton RF, Litten RZ, Slater M, Kranzler HR, Mann KF, Hasin DS, Johnson B, Meulien D, Ryan M, Fertig J, Alcohol Clinical Trials Initiative (ACTIVE) Workgroup
doi: 10.1001/jamapsychiatry.
Migraine and Headache
Retrospective review of thienopyridine therapy in migraineurs with patent foramen ovale
Neurology.
Sommer RJ, Nazif T, Privitera L, Robbins BT
doi: 10.1212/WNL.
Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials
PLoS Med.
Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Ballissant E,
Naudet F
doi: 10.1371/
Stroke
Risks and benefits of clopidogrel-aspirin in minor stroke or TIA: Time course analysis of CHANCE
Neurology.
Pan Y, Jing J, Chen W, Meng X, Li H, Zhao X, Liu L, Wang D, Johnston SC, Wang Y, Wang Y; CHANCE investigators
doi: 10.1212/
Multiple Sclerosis
Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis
CNS Drugs.
Mendes D, Alves C, Batel-Margues F
doi: 10.1007/s40263-016-0377-9
Psychosis and Schizophrenia
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis
Biol Psychiatry.
Amminger GP, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD
doi: 10.1016/j.biopsych.2019.08.030.
RECOMMENDED
Stroke
Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
doi: 10.1161/STROKEAHA.119.028669.
Stroke
Benefit of Endovascular Thrombectomy by Mode of Onset: Secondary Analysis of the DAWN Trial
Stroke.
Jadhav AP, Aghaebrahim A, Jankowitz BT, Haussen DC, Budzik RF, Bonafe A, Bhuva P, Yavagal DR, Hanel RA, Hassan AE, Ribo M, Cognard C, Sila CA, Zhang Y, Smith WS, Saver JL, Liebeskind DS, Nogueira RG, Jovin TG
doi: 10.1161/STROKEAHA.119.025795.
Stroke
Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source: NAVIGATE-ESUS Trial
Stroke.
Mikulík R, Eckstein J, Pearce LA, Mundl H, Rudilosso S, Olavarría VV, Shoamanesh A, Chamorro Á, Martí-Fàbregas J, Veltkamp R, Öztürk Ş, Tatlisumak T, Peacock WF, Berkowitz SD, Connolly SJ, Hart RG
doi: 10.1161/STROKEAHA.